HOOKIPA Pharma Inc.
Hedge Funds Holdings
Last updated:
HOOKIPA Pharma Inc.‘s stocks are currently a part of 23 hedge funds’ portfolios, which represents 12.85% of the total amount of its stocks outstanding. This makes up a total of 8.41M shares of HOOKIPA Pharma Inc.. Compared to the previous quarter, the number fell by -64.56% or -15.33M shares fewer. As for the holding position changes, 21.74% (5) of current hedge fund investors increased the number of shares held, 30.43% (7) of current holders sold a part of the shares held, and 21.74% (5) closed the holdings completely. 1 hedge funds are new holders of HOOKIPA Pharma Inc. stock in Q1 2023, it is 4.35% of total holders.
Hedge funds holding HOOKIPA Pharma (Q2 2018 – Q1 2023)
Q2 2018 | 1 |
---|---|
Q3 2018 | 1 |
Q4 2018 | 2 |
Q1 2019 | 1 |
Q2 2019 | 33 |
Q3 2019 | 35 |
Q4 2019 | 36 |
Q1 2020 | 42 |
Q2 2020 | 47 |
Q3 2020 | 48 |
Q4 2020 | 53 |
Q1 2021 | 62 |
Q2 2021 | 72 |
Q3 2021 | 69 |
Q4 2021 | 67 |
Q1 2022 | 67 |
Q2 2022 | 44 |
Q3 2022 | 45 |
Q4 2022 | 50 |
Q1 2023 | 23 |
Hedge funds changes in HOOKIPA Pharma positions (Q2 2018 – Q1 2023)
Q2 2018 | 1 | 0 | 0 | 1 | -1 |
---|---|---|---|---|---|
Q3 2018 | 1 | 0 | 0 | 1 | -1 |
Q4 2018 | 2 | 0 | 0 | 1 | -1 |
Q1 2019 | 0 | 1 | 0 | 1 | -1 |
Q2 2019 | 33 | 0 | 0 | 1 | -1 |
Q3 2019 | 7 | 13 | 8 | 4 | 3 |
Q4 2019 | 4 | 20 | 5 | 3 | 4 |
Q1 2020 | 8 | 17 | 13 | 2 | 2 |
Q2 2020 | 11 | 20 | 9 | 6 | 1 |
Q3 2020 | 6 | 13 | 18 | 5 | 6 |
Q4 2020 | 10 | 20 | 10 | 5 | 8 |
Q1 2021 | 17 | 18 | 15 | 8 | 4 |
Q2 2021 | 21 | 25 | 14 | 11 | 1 |
Q3 2021 | 10 | 22 | 24 | 13 | 0 |
Q4 2021 | 12 | 22 | 21 | 14 | -2 |
Q1 2022 | 16 | 19 | 26 | 16 | -10 |
Q2 2022 | 9 | 7 | 17 | 30 | -19 |
Q3 2022 | 6 | 11 | 11 | 5 | 12 |
Q4 2022 | 13 | 12 | 17 | 8 | 0 |
Q1 2023 | 1 | 5 | 7 | 5 | 5 |
Hedge funds changes in HOOKIPA Pharma stock options (Q2 2018 – Q1 2023)
Q2 2018 | 427,000 | 266,000 |
---|---|---|
Q3 2018 | 485,000 | 181,000 |
Q4 2018 | 76,000 | 8,000 |
Q1 2019 | 1,184,000 | 34,000 |
Q2 2019 | 3,222,000 | 92,000 |
Q3 2019 | 2,083,000 | 126,000 |
Q4 2019 | 952,000 | 405,000 |
Q1 2020 | 789,000 | 1,205,000 |
Q2 2020 | 703,000 | 2,135,000 |
Q3 2020 | 249,000 | 2,813,000 |
Q4 2020 | 6,000 | 1,731,000 |
Q1 2021 | 533,000 | 1,855,000 |
Q2 2021 | 326,000 | 2,178,000 |
Q3 2021 | 516,000 | 825,000 |
Q4 2021 | 64,000 | 89,000 |
Q1 2022 | 326,000 | 427,000 |
Q2 2022 | 195,000 | 143,000 |
Q3 2022 | 72,000 | 103,000 |
Q4 2022 | 36,630 | 32,805 |
Q1 2023 | 37,987,000 | 29,514,000 |